FDA finds fault with Facebook page; Validic raises $1.25M for data hub;

> Alleged misbranding of a drug on Facebook ($FB) has landed a company in trouble with FDA. News

> Mobile health data aggregator Validic has raised a further $1.25 million and hired executives. Release

> A debate over conflicts of interest is at the center of a Virginia Bioinformatics Institute employment lawsuit. Article

> CRO Parexel ($PRXL) has joined AstraZeneca ($AZN) and Merck ($MRK) on Exostar's cloud-based life sciences hub. Piece

> BioClinica has discussed its role in Pharmacyclics' ($PCYC) accelerated approval. Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.